Almost all genetic therapies involving the eye are targeting rare inherited diseases.
Our mission is to design genetic treatments for common age-related eye diseases, which affect all people and are considered unavoidable.
We have identified a pathway to accelerate the development and approval of our gene therapy products. The plan includes detailed research and pre‐clinical testing, clinical trials with collaborators, regulatory strategies, and partnerships with leading manufacturing platforms to produce high‐quality products. Our goal is to bring these therapies safely to people.
If you are an investor interested in making a meaningful impact while seeking
please fill out the following form: